In re Chevenard’s Empirical Analysis
139 F.2d 709 · 1943
Citation profile
1
cited by 1 later decisions
December 1943
most recently cited
Relationships
Relies on In re Chevenard
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 1 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
““8. A process for the manufacture of compensating spiral springs for watches, chronometers and the like, which comprises the steps of taking an austenitic iron-nickel alloy, containing 28-42% of nickel, 0.3-1% of carbon, 4-8% of chromium, 0.5-2% of manganese, 0.2-1% of silicon and additionally a small proportion of at least one of the elements taken from a group consisting of tungsten, molybdenum, vanadium, titanium, aliminium, copper and cobalt for entering into solid solution in the austenite so as to modify its thermoelastic anomaly, and at the same time forming complex carbides which are more soluble hot than cold in the austenite, subjecting it to a gradual wire drawing, with reheatings between the passes, down to a diameter from about 0.4 to about 1 mm, subjecting the wire to a hyperquenching, continuing wire drawing without intermediary reheating, rolling the wire into a ribbon of the desired transverse section, winding the ribbon into a spiral form and finally fixing the latter by heating to temperatures of 550 to 750° C.” “10. A process as set forth in claim 8 in which an alloy is taken comprising 28-42% Ni, 4-8% Cr, 0.5-4% W, 0.5-2% Mn, 0.2-1% Si, 0.3-1% C and at least two of the element Mo, Va, Ti and Al in a total amounting to at least 0.5% and at most 4%, as well as Fe to make up 100.””
1 later decision quote this exact passagee.g. In re Chevenard
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.